We Are in the Middle of a Depression Epidemic. And Our Main Tool Is Not Enough

Depression affects hundreds of millions of people worldwide — but the full scale of the epidemic includes a much larger, quieter group who live with significant symptoms without ever receiving a diagnosis. In this post, behavioral scientist and psychedelic facilitator Ioana explores the limits of current antidepressant treatment, the growing evidence for psychedelics as a genuinely different approach, and why the mechanism matters as much as the outcome. Part one of two.